SACRAMENTO — Six days after Theranos Inc. confirmed it was forced to void thousands of unreliable blood test results, the Palo Alto-based startup was hit Wednesday with a class action complaint alleging fraud, unfair business practices and false advertising.
Attorneys with McCuneWright, representing a plaintiff identified only as M.P.B., are seeking to certify a national class and an Arizona subclass of Theranos customers. McCuneWright partner Joseph Sauder said the firm believes its complaint is the first to be filed after Theranos’ May 19 announcement.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
